Clinical Trials Logo

Clinical Trial Summary

RAPHE is an open label randomized clinical trial to assess physical, biological and chemical methods of radial artery puncture hemostasis following coronary catheterization. A total of 600 subjects will be randomized in a 1:1:1 fashion to either the StatSeal, Axiostat or TR Band hemostasis devices. Follow-up of the subject will take place 60 days after the index procedure.

Clinical Trial Description


Study Design

NCT number NCT04857385
Study type Interventional
Source Semmelweis University Heart and Vascular Center
Contact István F Édes, MD PhD
Phone +36-1-458-6810
Email [email protected]
Status Recruiting
Phase N/A
Start date April 14, 2021
Completion date January 1, 2023